{"id":68986,"date":"2026-03-12T15:07:16","date_gmt":"2026-03-12T15:07:16","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68986"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"adamax","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ja\/product\/adamax\/","title":{"rendered":"Adamax"},"content":{"rendered":"<p><!-- medsbase-related-alts-v1 --><\/p>\n<div class=\"medsbase-tldr-answer\" style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 16px 22px; margin: 0 0 24px 0; border-radius: 4px;\">\n<h3 style=\"margin-top: 0; font-size: 17px;\">\u30af\u30a4\u30c3\u30af\u30a2\u30f3\u30b5\u30fc \u2014 Adamax\u3068\u306f\uff1f<\/h3>\n<p style=\"margin: 0;\">Adamax is a peptide developed as a structural analogue of Semax, modified with an adamantane fragment (the same stabilizing motif used in P21). It is studied for endurance, recovery from physical exertion, and cognitive support \u2014 with study models reporting 2\u20133\u00d7 greater endurance effects than earlier Semax analogues. Sold as a compound; not approved for human therapeutic use.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>MedsBase\u3067\u5f97\u3089\u308c\u308b\u3082\u306e\uff1a<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/ja\/reviews\/\">\u30ab\u30b9\u30bf\u30de\u30fc\u30ec\u30d3\u30e5\u30fc<\/a><\/div>\n<h2>Adamax\u30da\u30d7\u30c1\u30c9 \u2014 \u6982\u8981<\/h2>\n<p>Adamax is an investigational peptide derived by modifying the Semax molecule with an adamantane fragment \u2014 the same hydrocarbon cage structure found in the nootropic candidate P21. That modification meaningfully alters two properties: membrane permeability and resistance to proteolytic breakdown. Both translate, in preclinical studies, into longer duration of action and more consistent blood\u2013brain barrier penetration. Scientific interest in Adamax centers on three parallel studies threads: (1) endurance and recovery under sustained physical load, (2) brain-derived neurotrophic factor (BDNF) expression in the hippocampus, and (3) sensitivity of the TrkB receptor \u2014 a key signaling hub for neuronal plasticity, memory consolidation, and mood regulation. These are the same pathways targeted by many classical nootropics, but Adamax&#8217;s adamantane stabilization allows it to be dosed less frequently while maintaining plasma and CNS concentrations. <\/p>\n<h2>Adamax\u306e\u4f5c\u7528\u6a5f\u5e8f\uff08\u60f3\u5b9a\uff09<\/h2>\n<p>Adamax shares Semax&#8217;s Pro-Gly-Pro backbone, a fragment derived from adrenocorticotropic hormone (ACTH) with no hormonal activity of its own. What it brings to the parent molecule is metabolic stability \u2014 where unmodified Semax is cleared quickly by peptidases, Adamax resists enzymatic degradation and produces a more sustained downstream signal. Three mechanisms have been described in studies publications:<\/p>\n<ul>\n<li><strong>BDNF\u306e\u30a2\u30c3\u30d7\u30ec\u30ae\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3<\/strong> \u2014 Adamax\u306f\u7279\u306b\u6d77\u99ac\u3067BDNF\u306e\u7523\u751f\u3092\u5897\u52a0\u3055\u305b\u307e\u3059\u3002BDNF\u306f\u3001\u5b66\u7fd2\u3068\u8a18\u61b6\u306e\u7d30\u80de\u57fa\u76e4\u3067\u3042\u308b\u9577\u671f\u5897\u5f37\u306b\u4e2d\u5fc3\u7684\u306a\u5f79\u5272\u3092\u679c\u305f\u3057\u307e\u3059\u3002<\/li>\n<li><strong>TrkB\u53d7\u5bb9\u4f53\u306e\u611f\u53d7\u6027\u5897\u5f37<\/strong> \u2014 BDNF\u81ea\u4f53\u306e\u4e0a\u6607\u306b\u52a0\u3048\u3066\u3001Adamax\u306f\u305d\u306e\u4e3b\u8981\u53d7\u5bb9\u4f53\uff08TrkB\uff09\u306e\u5fdc\u7b54\u6027\u3092\u9ad8\u3081\u3001\u540c\u7b49\u306e\u30ea\u30ac\u30f3\u30c9\u6fc3\u5ea6\u3067\u4e0b\u6d41\u306e\u52b9\u679c\u3092\u5897\u5e45\u3059\u308b\u3068\u307f\u3089\u308c\u3066\u3044\u307e\u3059\u3002<\/li>\n<li><strong>\u30b9\u30c8\u30ec\u30b9\u5fdc\u7b54\u8ef8\u306e\u8abf\u7bc0<\/strong> \u2014 ACTH\u65ad\u7247\u7531\u6765\u306e\u6027\u8cea\u306b\u3088\u308a\u3001\u8eab\u4f53\u7684\u307e\u305f\u306f\u7cbe\u795e\u7684\u8ca0\u8377\u306b\u5bfe\u3059\u308b\u30b3\u30eb\u30c1\u30be\u30fc\u30eb\u3068HPA\u8ef8\u306e\u5fdc\u7b54\u3092\u9069\u5ea6\u306b\u8abf\u7bc0\u3057\u3001\u8272\u7d20\u6c88\u7740\u4f5c\u7528\u3092\u5f15\u304d\u8d77\u3053\u3059\u30e1\u30e9\u30ce\u30b3\u30eb\u30c1\u30f3\u53d7\u5bb9\u4f53\u306b\u306f\u7d50\u5408\u3057\u307e\u305b\u3093\u3002<\/li>\n<\/ul>\n<p>Studies reports suggest the adamantane modification produces endurance effects roughly two to three times stronger than the parent Semax molecule when dosed on an equivalent molar basis. For a detailed treatment of the Semax lineage and the broader nootropic-peptide family, see our <a href=\"https:\/\/medsbase.com\/ja\/semax-peptide-nootropic-guide\/\">Semax\u30da\u30d7\u30c1\u30c9\u30ac\u30a4\u30c9<\/a>. <\/p>\n<h2>\u6eb6\u89e3\u3001\u4fdd\u7ba1\u3001\u304a\u3088\u3073\u53d6\u308a\u6271\u3044<\/h2>\n<p>Adamax\u306f\u51cd\u7d50\u4e7e\u71e5\u54c1\uff08\u30d5\u30ea\u30fc\u30ba\u30c9\u30e9\u30a4\uff09\u3068\u3057\u3066\u4f9b\u7d66\u3055\u308c\u307e\u3059\u3002\u7814\u7a76\u5ba4\u3067\u306f\u901a\u5e38\u3001\u4f7f\u7528\u524d\u306b\u9759\u83cc\u6c34\u3067\u6eb6\u89e3\u3057\u307e\u3059 \u2014 \u5f53\u793e\u306e <a href=\"https:\/\/medsbase.com\/ja\/bac-water\/\">BAC Water\u88fd\u54c1<\/a> \u306f\u3053\u306e\u76ee\u7684\u306e\u305f\u3081\u306b\u8abf\u88fd\u3055\u308c\u3066\u304a\u308a\u3001 <a href=\"https:\/\/medsbase.com\/ja\/bac-water-reconstitution-guide\/\">BAC\u6c34\u6eb6\u89e3\u30ac\u30a4\u30c9<\/a> \u304c\u6a19\u6e96\u30d7\u30ed\u30c8\u30b3\u30eb\u3092\u89e3\u8aac\u3057\u3066\u3044\u307e\u3059\u3002 <\/p>\n<ul>\n<li>\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u306f2\uff5e8\u2103\uff08\u51b7\u8535\uff09\u3067\u4fdd\u7ba1\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u8f38\u9001\u4e2d\u306b\u77ed\u6642\u9593\u5ba4\u6e29\u306b\u3055\u3089\u3055\u308c\u3066\u3082\u3001\u901a\u5e38\u306f\u554f\u984c\u3042\u308a\u307e\u305b\u3093\u3002<\/li>\n<li>\u6eb6\u89e3\u5f8c\u306f\u51b7\u8535\u4fdd\u5b58\u3057\u3001\u5b89\u5b9a\u6027\u3092\u6700\u9069\u306b\u4fdd\u3064\u305f\u308130\u65e5\u4ee5\u5185\u306b\u3054\u4f7f\u7528\u304f\u3060\u3055\u3044\u3002<\/li>\n<li>\u7e70\u308a\u8fd4\u3057\u51cd\u7d50\u878d\u89e3\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002\u6c37\u306e\u7d50\u6676\u304c\u30da\u30d7\u30c1\u30c9\u306e\u4e09\u6b21\u69cb\u9020\u3092\u7834\u58ca\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/li>\n<li>\u76f4\u5c04\u65e5\u5149\u3092\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002\u8910\u8272\u307e\u305f\u306f\u30a2\u30eb\u30df\u30db\u30a4\u30eb\u3067\u5305\u3093\u3060\u30d0\u30a4\u30a2\u30eb\u304c\u63a8\u5968\u3055\u308c\u307e\u3059\u3002<\/li>\n<\/ul>\n<h2>Dosing Protocols<\/h2>\n<p>Dosing in published studies protocols varies by endpoint. For endurance and physical-recovery studies, intranasal administration of 200\u2013400 \u00b5g once or twice daily is common. For cognitive endpoints, higher single doses up to 600 \u00b5g have been used. These figures reflect clinical studies conditions and are not prescribing recommendations \u2014 Adamax is not approved for therapeutic use in any jurisdiction. Cycle length in clinical settings typically ranges from 10 to 21 days, followed by a washout period at least equal in length. Extended continuous exposure has not been adequately characterized. <\/p>\n<h2>\u5b89\u5168\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb<\/h2>\n<p>As a modified Pro-Gly-Pro heptapeptide with no receptor binding outside the BDNF\/TrkB axis and mild HPA modulation, Adamax has a studies-phase safety signal similar to Semax: generally well tolerated in short-term use, with occasional reports of headache, mild insomnia if dosed late, and transient nasal irritation with intranasal administration. The longer half-life conferred by the adamantane modification is a double-edged sword \u2014 it improves dosing convenience but also means adverse effects, if they occur, persist longer. Studies personnel should start at the low end of the dose range and avoid late-day administration. Contraindications in protocols: pregnancy, lactation, active psychiatric medication, and any acute neurological condition under investigation. Because long-term human safety data is absent, Adamax is explicitly restricted to clinical studies and is not sold for therapeutic self-administration. <\/p>\n<h2>\u30da\u30d7\u30c1\u30c9\u30af\u30e9\u30b9\u30bf\u30fc\u306b\u304a\u3051\u308bAdamax<\/h2>\n<p>Adamax sits in the cognitive-enhancement branch of the peptide studies landscape. Related compounds frequently investigated alongside it include:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ja\/semax-peptide-nootropic-guide\/\">Semax<\/a> \u2014 \u6bcd\u4f53\u3068\u306a\u308bPro-Gly-Pro\u30d8\u30d7\u30bf\u30da\u30d7\u30c1\u30c9\u3002Adamax\u306e\u76f4\u63a5\u306e\u524d\u99c6\u4f53\u3067\u3059\u3002<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ja\/nad-plus-coenzyme-longevity-guide\/\">NAD+<\/a> \u2014 a coenzyme used in longevity and mitochondrial-function studies; often studied in combination with nootropic peptides.<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ja\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157<\/a> \u2014 the recovery peptide most commonly stacked with cognitive compounds in protocols exploring training adaptation.<\/li>\n<\/ul>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 \u3059\u3079\u3066\u306e\u3054\u6ce8\u6587\u306f\u3001\u5f53\u5e97\u306e <a href=\"https:\/\/medsbase.com\/ja\/medsbase-re-shipment-assurance-policy\/\"><strong>\u518d\u767a\u9001\u4fdd\u8a3c\u30dd\u30ea\u30b7\u30fc<\/strong><\/a> \u2014 \u4e07\u304c\u4e00\u300120\u55b6\u696d\u65e5\u4ee5\u5185\u306b\u5546\u54c1\u304c\u5c4a\u304b\u306a\u3044\u5834\u5408\u306f\u3001\u518d\u767a\u9001\u3044\u305f\u3057\u307e\u3059\u3002<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">\u4ed5\u69d8<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">\u8a73\u7d30<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS\u756a\u53f7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Not formally registered (compound)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u5f0f<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>47<\/sub>H<sub>65<\/sub>N<sub>9<\/sub>O<sub>10<\/sub>S\uff08\u63a8\u5b9a\u5024\u3001Semax\u30a2\u30df\u30c7\u30fc\u30c8\uff0b\u30a2\u30c0\u30de\u30f3\u30bf\u30f3\u4fee\u98fe\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u91cf<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u7d04948 Da\uff08\u63a8\u5b9a\u5024\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u914d\u5217<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NH<sub>2<\/sub> N\u672b\u7aef\u306b\u30a2\u30c0\u30de\u30f3\u30bf\u30f3\u4fee\u98fe<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5f62\u614b<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u7c89\u672b\uff08\u307e\u305f\u306f\u4f9b\u7d66\u6642\u306e\u5f62\u614b\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u7d14\u5ea6<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599%\uff08HPLC\u691c\u8a3c\u6e08\u307f\u3001COA\u306f\u3054\u8981\u671b\u306b\u5fdc\u3058\u3066\u63d0\u4f9b\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u4fdd\u7ba1\u65b9\u6cd5<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u54c1\uff1a\u4f7f\u7528\u6642\u5728\u5eab\u306f2\uff5e8\u2103\uff08\u51b7\u8535\uff09\u306b\u4fdd\u7ba1\u3002\u672a\u958b\u5c01\u30d0\u30a4\u30a2\u30eb\u306e\u9577\u671f\u4fdd\u7ba1\u306b\u306f\u221220\u2103\u3002\u518d\u6eb6\u89e3\u5f8c\uff1a2\uff5e8\u2103\u3067\u7d0430\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3002\u5149\u304b\u3089\u4fdd\u8b77\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u518d\u6eb6\u89e3\u6db2\u306e\u51cd\u7d50\u878d\u89e3\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u6eb6\u89e3\u6027<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u9759\u83cc\u6c34\uff08\u63a8\u5968\uff09\u307e\u305f\u306f\u77ed\u6642\u9593\u4f7f\u7528\u306e\u5834\u5408\u306f\u6ec5\u83cc\u6c34<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 id=\"faqs\">\u3088\u304f\u3042\u308b\u8cea\u554f<\/h2>\n<h3>Adamax\u306fSemax\u3068\u540c\u3058\u3067\u3059\u304b\uff1f<\/h3>\n<p>No. Adamax is a structural analogue \u2014 it shares the Pro-Gly-Pro heptapeptide backbone of Semax but adds an adamantane fragment that confers greater metabolic stability and longer duration of action. Study models report roughly 2\u20133\u00d7 the endurance effect of unmodified Semax at equivalent molar doses. <\/p>\n<h3>Adamax\u3068P21\u306e\u9055\u3044\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u3069\u3061\u3089\u306e\u5316\u5408\u7269\u3082\u5b89\u5b9a\u5316\u30e2\u30c1\u30fc\u30d5\u3067\u3042\u308b\u30a2\u30c0\u30de\u30f3\u30bf\u30f3\u3092\u542b\u3093\u3067\u3044\u307e\u3059\u304c\u3001\u57fa\u76e4\u3068\u306a\u308b\u30da\u30d7\u30c1\u30c9\u9aa8\u683c\u304c\u7570\u306a\u308a\u307e\u3059\u3002P21\u306f\u6bdb\u69d8\u4f53\u795e\u7d4c\u6804\u990a\u56e0\u5b50\uff08CNTF\uff09\u65ad\u7247\u3092\u57fa\u306b\u69cb\u7bc9\u3055\u308c\u3066\u304a\u308a\u3001Adamax\u306fSemax\uff08Pro-Gly-Pro \/ ACTH 4\u201310\uff09\u9aa8\u683c\u3092\u57fa\u306b\u69cb\u7bc9\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4e21\u8005\u306f\u8a8d\u77e5\u6a5f\u80fd\u30a8\u30f3\u30c9\u30dd\u30a4\u30f3\u30c8\u306b\u95a2\u3057\u3066\u4e26\u884c\u3057\u3066\u7814\u7a76\u3055\u308c\u3066\u3044\u307e\u3059\u304c\u3001\u4e92\u63db\u6027\u306f\u3042\u308a\u307e\u305b\u3093\u3002 <\/p>\n<h3>How is Adamax typically administered in studies?<\/h3>\n<p>The most common administration route is intranasal, at 200\u2013400 \u00b5g one to two times daily for endurance and recovery endpoints, and up to 600 \u00b5g for cognitive studies. Subcutaneous administration is also described in some protocols. All routes are clinical-studies only. <\/p>\n<h3>How long before Adamax effects are observed in studies?<\/h3>\n<p>\u516c\u8868\u3055\u308c\u3066\u3044\u308b\u52d5\u7269\u7814\u7a76\u3067\u306f\u3001\u7d4c\u9f3b\u6295\u4e0e\u5f8c30\uff5e60\u5206\u4ee5\u5185\u306b\u6025\u6027\u306e\u6301\u4e45\u529b\u52b9\u679c\u304c\u6e2c\u5b9a\u53ef\u80fd\u3067\u3059\u3002BDNF\u4e0a\u65b9\u5236\u5fa1\u304a\u3088\u3073\u53ef\u5851\u6027\u30a8\u30f3\u30c9\u30dd\u30a4\u30f3\u30c8\u306e\u7d2f\u7a4d\u52b9\u679c\u306f\u3001\u901a\u5e38\u3001\u7d99\u7d9a\u6295\u4e0e\u306e7\uff5e14\u65e5\u5f8c\u306b\u73fe\u308c\u307e\u3059\u3002 <\/p>\n<h3>Adamax\u306f\u3069\u306e\u3088\u3046\u306b\u4fdd\u7ba1\u3059\u3079\u304d\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u51cd\u7d50\u4e7e\u71e5\uff08\u30d5\u30ea\u30fc\u30ba\u30c9\u30e9\u30a4\uff09\u30d0\u30a4\u30a2\u30eb\u306f\u30012\uff5e8 \u00b0C\u3067\u906e\u5149\u3057\u3066\u4fdd\u7ba1\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u9759\u83cc\u6c34\u3067\u6eb6\u89e3\u5f8c\u306f\u3001\u6eb6\u6db2\u3092\u51b7\u8535\u3057\u300130\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u51cd\u7d50\u878d\u89e3\u306e\u7e70\u308a\u8fd4\u3057\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h3>Adamax\u306e\u6eb6\u89e3\u306b\u306f\u4f55\u3092\u4f7f\u7528\u3057\u307e\u3059\u304b\uff1f<\/h3>\n<p>Bacteriostatic water (0.9% benzyl alcohol) is the standard reconstitution diluent for most peptides including Adamax. Sterile saline can be used but shortens the in-use stability window because it contains no preservative. <\/p>\n<h3>Adamax\u306fFDA\u306b\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>No. Adamax is not approved by the FDA, EMA, MHRA, TGA, or any other regulatory authority for human therapeutic use. It is supplied as a compound for clinical investigation only. <\/p>\n<h3>Can Adamax be stacked with BPC-157 or TB-500 in studies?<\/h3>\n<p>In protocols exploring combined recovery and cognitive adaptation, investigators have studied Adamax alongside BPC-157 or TB-500. Each compound targets a different pathway, so interaction at the pharmacological level is minimal \u2014 but combination studies designs should still be statistically powered to detect main and interaction effects separately. <\/p>\n<h3>What side effects are reported in Adamax studies?<\/h3>\n<p>\u6700\u3082\u4e00\u822c\u7684\u306a\u3082\u306e\uff1a\u8efd\u5ea6\u306e\u982d\u75db\u3001\u7d4c\u9f3b\u6295\u4e0e\u6642\u306e\u4e00\u904e\u6027\u306e\u9f3b\u523a\u6fc0\u3001\u305d\u3057\u3066\u5915\u65b9\u3084\u591c\u9593\u306e\u6295\u4e0e\u3067\u6642\u6298\u898b\u3089\u308c\u308b\u4e0d\u7720\u3002Semax\u3068\u6bd4\u8f03\u3057\u3066\u4f5c\u7528\u6642\u9593\u304c\u9577\u3044\u305f\u3081\u3001\u526f\u4f5c\u7528\u304c\u767a\u751f\u3057\u305f\u5834\u5408\u3001\u305d\u306e\u6301\u7d9a\u6642\u9593\u3082\u9577\u304f\u306a\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002 <\/p>\n<h3>Adamax\u306f\u3069\u306e\u3088\u3046\u306b\u8840\u6db2\u8133\u95a2\u9580\u3092\u901a\u904e\u3057\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u30a2\u30c0\u30de\u30f3\u30bf\u30f3\u90e8\u5206\u306f\u672a\u4fee\u98fe\u306eSemax\u3068\u6bd4\u8f03\u3057\u3066\u89aa\u6cb9\u6027\u3092\u9ad8\u3081\u3001\u8840\u6db2\u8133\u95a2\u9580\u3092\u4ecb\u3057\u305f\u53d7\u52d5\u62e1\u6563\u3092\u4fc3\u9032\u3059\u308b\u3068\u8003\u3048\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u3055\u3089\u306b\u3001\u9f3b\u8154\u5185\u6295\u4e0e\u306f\u55c5\u899a\u7d4c\u8def\u304a\u3088\u3073\u4e09\u53c9\u795e\u7d4c\u7d4c\u8def\u3092\u5229\u7528\u3057\u3066\u3001\u521d\u56de\u901a\u904e\u4ee3\u8b1d\u3092\u56de\u907f\u3057\u3001\u9f3b\u304b\u3089\u8133\u3078\u306e\u76f4\u63a5\u7684\u306a\u79fb\u884c\u3092\u53ef\u80fd\u306b\u3057\u307e\u3059\u3002 <\/p>\n<h3>Adamax\u306f\u56fd\u969b\u914d\u9001\u3057\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u306f\u3044\u3002\u30da\u30d7\u30c1\u30c9\u306e\u307f\u306e\u3054\u6ce8\u6587\u306f\u3001\u5c02\u7528\u306e\u30da\u30d7\u30c1\u30c9\u914d\u9001\u696d\u8005\u3092\u5229\u7528\u3057\u3066\u5168\u4e16\u754c\u914d\u9001\u3055\u308c\u3001\u30da\u30d7\u30c1\u30c9\u306e\u307f\u3092\u542b\u3080\u3054\u6ce8\u6587\u3067\u306f\u8ffd\u52a0\u6599\u91d1\u306a\u3057\u3067\u3054\u5229\u7528\u3044\u305f\u3060\u3051\u307e\u3059\u3002\u6df7\u5408\u6ce8\u6587\uff08\u30da\u30d7\u30c1\u30c9\u3068\u4ed6\u306e\u533b\u85ac\u54c1\u3092\u542b\u3080\uff09\u306e\u5834\u5408\u306f\u3001\u6a19\u6e96\u306e\u8ffd\u8de1\u4ed8\u304d\u56fd\u969b\u914d\u9001\u30aa\u30d7\u30b7\u30e7\u30f3\u3092\u4f7f\u7528\u3057\u307e\u3059\u3002 <\/p>\n<h3>Adamax\u306e\u534a\u6e1b\u671f\u306f\u3069\u306e\u304f\u3089\u3044\u3067\u3059\u304b\uff1f<\/h3>\n<p>Adamax has a significantly longer estimated half-life than its parent compound Semax, due to the adamantane modification which resists enzymatic degradation. Exact plasma half-life data from formal pharmacokinetic studies are limited; protocols typically use once-daily intranasal administration based on reported duration of cognitive effects. <\/p>\n<h3>Adamax\u306fSemax\u3088\u308a\u5f37\u529b\u3067\u3059\u304b\uff1f<\/h3>\n<p>Adamax is a structural modification of Semax designed for enhanced potency and extended half-life. The adamantane group is reported to increase binding affinity at TrkB (BDNF receptor) and extend the duration of BDNF upregulation compared to unmodified Semax. Formal head-to-head potency comparisons in peer-reviewed literature are limited; available data come from preclinical models and self-reported studies observations. <\/p>\n<h3>MedsBase\u306fAdamax\u3092\u3069\u306e\u3088\u3046\u306a\u7d14\u5ea6\u57fa\u6e96\u3067\u4f9b\u7d66\u3057\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>MedsBase\u304c\u53d6\u308a\u6271\u3046\u3059\u3079\u3066\u306eAdamax\u30d0\u30a4\u30a2\u30eb\u306f\u3001\u51cd\u7d50\u4e7e\u71e5\u5f62\u614b\u3067HPLC\u7d14\u5ea699%\u4ee5\u4e0a\u3067\u4f9b\u7d66\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5206\u6790\u8a3c\u660e\u66f8\uff08COA\uff09\u306f\u3054\u8981\u671b\u306b\u5fdc\u3058\u3066\u5165\u624b\u53ef\u80fd\u3067\u3059\u3002\u3054\u6ce8\u6587\u5f8c\u306b\u30b5\u30dd\u30fc\u30c8\u30c1\u30fc\u30e0\u306b\u30e1\u30c3\u30bb\u30fc\u30b8\u3092\u304a\u9001\u308a\u3044\u305f\u3060\u3051\u308c\u3070\u3001\u304a\u53d7\u3051\u53d6\u308a\u306b\u306a\u3063\u305f\u30d0\u30a4\u30a2\u30eb\u306e\u30ed\u30c3\u30c8\u56fa\u6709\u306eCOA\u3092\u304a\u9001\u308a\u3057\u307e\u3059\u3002 <!-- medsbase-peptide-guide-cta --><\/p>\n<h2>\u53c2\u8003\u6587\u732e<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">\u30a8\u30d3\u30c7\u30f3\u30b9\u306b\u57fa\u3065\u304f\u5b8c\u5168\u30ac\u30a4\u30c9\u3092\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a href=\"https:\/\/medsbase.com\/ja\/adamax-peptide-nootropic-guide\/\"><strong>Adamax \u2014 mechanism, data &amp; outlook<\/strong><\/a>. Covers mechanism of action, published study data, typical dosing ranges, reconstitution protocols, stacking considerations, and safety\/contraindication notes.<\/p>\n<\/div>\n<p><!-- medsbase-peptide-cluster-footer --><\/p>\n<div style=\"background: #eef7ee; border-left: 4px solid #4caf50; padding: 16px 22px; margin: 24px 0; border-radius: 4px;\">\n<h3 style=\"margin-top: 0; font-size: 16px;\">Related Peptide Guides<\/h3>\n<ul style=\"margin: 8px 0 0 0;\">\n<li><a href=\"https:\/\/medsbase.com\/ja\/adamax-peptide-nootropic-guide\/\">Adamax Peptide \u2014 Nootropic &amp; Endurance Guide<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ja\/semax-peptide-nootropic-guide\/\">Semax \u2014 \u89aa\u5411\u77e5\u6027\u30da\u30d7\u30c1\u30c9<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ja\/nad-plus-coenzyme-longevity-guide\/\">NAD+ for Mitochondrial &amp; Longevity Studies<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ja\/peptides\/\">All Peptides at MedsBase<\/a><\/li>\n<\/ul>\n<\/div>\n<p><!-- \/medsbase-peptide-cluster-footer --><br \/>\n<!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705\u8a8d\u77e5\u6a5f\u80fd\u3092\u30b5\u30dd\u30fc\u30c8<br \/>\n\u2705 \u7cbe\u795e\u7684\u306a\u660e\u6670\u3055\u3092\u5411\u4e0a<br data-is-only-node=\"\" \/>\u2705 \u795e\u7d4c\u53ef\u5851\u6027\u3092\u4fc3\u9032<br \/>\n\u2705 \u795e\u7d4c\u7d30\u80de\u306e\u56de\u5fa9\u529b\u3092\u4fc3\u9032<br \/>\n\u2705 \u96c6\u4e2d\u529b\u3068\u8a18\u61b6\u529b\u3092\u6539\u5584<\/p>\n<p data-is-last-node=\"\" data-is-only-node=\"\"><strong>Adamax<\/strong> \u5408\u6210\u30da\u30d7\u30c1\u30c9\u5316\u5408\u7269\u3092\u542b\u307f\u307e\u3059\u3002<\/p>","protected":false},"featured_media":70941,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5469],"class_list":["post-68986","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-adamax","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product\/68986","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/comments?post=68986"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media\/70941"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media?parent=68986"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_brand?post=68986"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_cat?post=68986"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_tag?post=68986"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}